These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 769680)

  • 1. Toxicity of nalidixic acid on candida albicans, Saccharomyces cerevisiae, and Kluyveromyces lactis.
    Sobieski RJ; Brewer AR
    Antimicrob Agents Chemother; 1976 Mar; 9(3):485-92. PubMed ID: 769680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population changes induced in Candida albicans by nalidixic acid.
    Sarachek A
    Mycopathologia; 1979 Sep; 68(2):105-20. PubMed ID: 386130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transmission and expression of mutations to nalidixic acid resistance among products of protoplast fusion crosses of Candida albicans.
    Haught MA; Sarachek A
    Mutat Res; 1985 Oct; 152(1):15-23. PubMed ID: 3900712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nalidixic acid inhibition of post-ultraviolet recovery by nalidixic acid sensitive and resistant strains of Candida albicans.
    Sarachek A; Lee SC
    Z Allg Mikrobiol; 1980; 20(2):141-7. PubMed ID: 6990642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intergeneric transfer of deoxyribonucleic acid killer plasmids, pGKl1 and pGKl2, from Kluyveromyces lactis into Saccharomyces cerevisiae by cell fusion.
    Gunge N; Sakaguchi K
    J Bacteriol; 1981 Jul; 147(1):155-60. PubMed ID: 7016841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the action of nalidixic acid in the yeast Saccharomyces cerevisiae.
    Michaels CA; Blamire J; Goldfinger B; Marmur J
    Antimicrob Agents Chemother; 1973 May; 3(5):562-7. PubMed ID: 4597731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2'-Deoxyadenosine and A23187 as agents for inducing synchrony in the budding yeast, Kluyveromyces fragilis.
    Penman CS; Duffus JH
    J Gen Microbiol; 1975 Sep; 90(1):76-80. PubMed ID: 1100777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anethole potentiates dodecanol's fungicidal activity by reducing PDR5 expression in budding yeast.
    Fujita KI; Ishikura T; Jono Y; Yamaguchi Y; Ogita A; Kubo I; Tanaka T
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):477-484. PubMed ID: 27632201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transformations of inorganic mercury by Candida albicans and Saccharomyces cerevisiae.
    Yannai S; Berdicevsky I; Duek L
    Appl Environ Microbiol; 1991 Jan; 57(1):245-7. PubMed ID: 2036011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro activity of antifungal agents in combination with four quinolones.
    Petrou MA; Rogers TR
    Drugs Exp Clin Res; 1988; 14(1):9-18. PubMed ID: 3292181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetration of nalidixic acid in the cell cycle of Escherichia coli K-12.
    Hrebenda J; Brzostek K; Heleszko H
    Acta Microbiol Pol; 1986; 35(3-4):241-9. PubMed ID: 2436451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations sensitizing yeast cells to the start inhibitor nalidixic acid.
    Prendergast JA; Singer RA; Rowley N; Rowley A; Johnston GC; Danos M; Kennedy B; Gaber RF
    Yeast; 1995 May; 11(6):537-47. PubMed ID: 7645344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin potentiates the fungicidal effect of dodecanol by inhibiting drug efflux in wild-type budding yeast.
    Yamawaki C; Oyama M; Yamaguchi Y; Ogita A; Tanaka T; Fujita KI
    Lett Appl Microbiol; 2019 Jan; 68(1):17-23. PubMed ID: 30276838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divergent functions of three Candida albicans zinc-cluster transcription factors (CTA4, ASG1 and CTF1) complementing pleiotropic drug resistance in Saccharomyces cerevisiae.
    Coste AT; Ramsdale M; Ischer F; Sanglard D
    Microbiology (Reading); 2008 May; 154(Pt 5):1491-1501. PubMed ID: 18451058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of chlorhexidine diacetate on Candida albicans, C. glabrata and Saccharomyces cerevisiae.
    Hiom SJ; Furr JR; Russell AD; Dickinson JR
    J Appl Bacteriol; 1992 Apr; 72(4):335-40. PubMed ID: 1517175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrachromosomal inheritance of nalidixic acid resistance in the petite negative yeast Schizosaccharomyces pombe.
    Massardo DR; Del Giudice L; Manna F; Wolf K
    Mol Gen Genet; 1982; 187(1):96-100. PubMed ID: 6962314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological assay of fungicides against yeasts in vitro using a coulter counter.
    Brotherton J
    Mykosen; 1976 Oct; 19(10):361-72. PubMed ID: 794710
    [No Abstract]   [Full Text] [Related]  

  • 18. Interconversion of polyamines in wild-type strains and mutants of yeasts and the effects of polyamines on their growth.
    Hamana K; Matsuzaki S; Hosaka K; Yamashita S
    FEMS Microbiol Lett; 1989 Oct; 52(1-2):231-6. PubMed ID: 2689281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterization of linear deoxyribonucleic acid plasmids from Kluyveromyces lactis and the plasmid-associated killer character.
    Gunge N; Tamaru A; Ozawa F; Sakaguchi K
    J Bacteriol; 1981 Jan; 145(1):382-90. PubMed ID: 6257636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capsicum annuum L. trypsin inhibitor as a template scaffold for new drug development against pathogenic yeast.
    Ribeiro SF; Silva MS; Da Cunha M; Carvalho AO; Dias GB; Rabelo G; Mello EO; Santa-Catarina C; Rodrigues R; Gomes VM
    Antonie Van Leeuwenhoek; 2012 Mar; 101(3):657-70. PubMed ID: 22160750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.